Search results for: 'environmental impact analysis production of robot diamonds'

07 Aug 2024  |  Global  |  Market Research

Non-surgical Healthcare Robots Sector, Global, 2024 2028

Regulatory Approvals, Reimbursement Policies, and Leasing Plans Are Driving Transformational Growth by Supporting Healthcare Centers in Implementing Hospital Operations, Nursing Assistant, and Patient Assistant Robots

Infographics

×

Key Benefits

This Frost & Sullivan analysis covers innovative devices propelling industry growth as well as market trends and emerging business models that will dominate the non-surgical healthcare robots sector. Highlights include a look at cutting-edge solutions in the non-surgical healthcare robots industry, including hospital operations robots, nursing assi...

The research study analyzes how emerging surgical robotics technologies are evolving in response to pressing unmet needs across hospitals and ambulatory surgical centers (ASCs) such as high cost of ownership, operating room (OR) efficiency bottlenecks, reprocessing workload, and interoperability gaps.It highlights how companies are actively solving...

The global care assistance and automation robots market is expected to achieve rapid adoption with a CAGR of 36% through 2021. As doctors and care providers pay more attention to patients, leaving daily tasks for the efficient handling of robotic systems, patients will receive improved quality of care and reduced hospital readmission, the prime rea...

Robotic-assisted surgical devices (RASDs) have transformed surgical practice by enhancing precision, dexterity, and control during complex procedures. Robotic technology helps surgeons in terms of ergonomics, motion scaling, and tremor filtration. Pay-per-use models or leasing options can alleviate concerns about high acquisition and maintenance co...

Frost & Sullivan estimates the aging population and accompanying retirements to cause a significant physician shortfall of 55,000 to 150,000 by 2030, creating a gap in the healthcare system. Expanding the role of autonomous robots can mitigate the shortage. The healthcare sector is forecast to expand rapidly with the decentralization of institu...

Rising incidents of patient deaths are raising questions about medical device efficacy, specifically Class II and Class III medical devices. All medical devices commercialized in the US market must adhere to 510(k) compliance. The US Food and Drug Administration (FDA) posts summaries of information about the most serious medical device recalls. ...

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

Single-cell analysis can diagnose a condition in heterogenous cell population samples by studying genomics, transcriptomics, proteomics, metabolomics, and other cellular interactions in cells. It helps to understand a tumor microenvironment better and develop drugs based on newly uncovered knowledge of various types of tumors. The rich data provide...

Immunoglobulin therapies are life-saving medicines that have been in use for more than 60 years. They provide the patient with a variety of antibodies and are often used as a last line of defense in many severe inflammatory diseases. In some conditions, they are life-saving. However, immunoglobulin therapies are expensive. Despite this, global dem...